This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
DUBLIN, Ireland, Sept. 12, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that Roger Boissonneault, President and Chief Executive Officer, and Paul Herendeen, Executive Vice President and Chief Financial Officer, are scheduled to present at the 2012 UBS Global Life Sciences Conference on Wednesday, September 19
th at 10:00 a.m. EDT.
The presentation will be simultaneously webcast at
http://ir.wcrx.com/events.cfm , with an archived replay of the webcast available shortly thereafter at
Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the pharmaceutical markets, primarily in North America. The Company is fully integrated with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G
CONTACT: Emily Hill